Today, Xpeng held its AI Day 2025 at its new headquarters in Guangzhou. The automaker is positioning itself as ...
HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage activation, T-cell restoration, and tumor microenvironment remodeling in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback